induction & maintenance therapy in elderly patients with mcl: insights from the mcl-r2 elderly trial
Published 8 months ago • 74 plays • Length 3:07Download video MP4
Download video MP3
Similar videos
-
10:34
remission induction therapy prior to allosct in aml: insights from the asap trial
-
2:04
autologous transplantation followed by maintenance vs maintenance alone in patients with mcl
-
2:34
exploring chemotherapy-free induction treatment for patients with ph all
-
3:44
current treatment options and emerging strategies in mcl
-
2:03
the mcl complete project: nationwide data collection
-
1:19
astx727 a molecularly-targeted agent as personalized maintenance therapy in patients with aml
-
2:15
autohsct in mcl in early vs late in the treatment regimen
-
2:15
the toxicity of induction therapy in aml
-
2:09
the optimal sequencing of novel therapies in mantle cell lymphoma
-
2:07
the importance of induction chemotherapy in the aml treatment
-
2:45
continuity of care for patients with hematological predispositions to aml
-
3:16
the optimization of induction chemotherapy for patients with aml
-
2:50
the impact of induction therapy on post-transplant outcomes in aml
-
1:39
optimizing chemotherapy in aml
-
1:37
the role of ctdna in hodgkin lymphoma
-
3:34
effect of time to relapse on os in mcl following autohct
-
2:31
evaluating the safety of maintenance therapy cessation in mrd negative myeloma patients
-
2:03
maintenance therapy in aml